Over the years, the company has significantly grown its portfolio of products across mass and specialty therapies. Today, our portfolio has over 200 products covering the whole spectrum of disease areas spanning gastroenterology, oncology, pain management, cardiovascular, dermatology, urology, nephrology, rheumatology and diabetes. Seven of our brands are listed in “Top-300 of the Indian Pharma Market” and many others hold leadership positions in their respective categories.